Home Search
drug development - search results
If you're not happy with the results, please do another search
Malaria deaths reduced by 70% with vaccine and drug combination
A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
Using human models of brain development to understand autism
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Combination of remdesivir and hep C drugs effective against COVID-19
A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
The changing perspective of psychedelic drugs with a history of abuse
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Polymers and polymer-based drug delivery in the treatment of dry eye disease
Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.
Existing drugs could be used to fight COVID-19 in elderly patients
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
COVID-19 and drugs in the European neighbourhood partnership countries
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Scientists identify possible drug to fight incurable childhood cancer
Diffuse Intrinsic Pontine Glioma (DIPG) is an incurable childhood cancer that has no effective treatment - but now, scientists in Australia believe they have found a drug that could begin to treat this cancer.
Childhood trauma linked to multiple sclerosis development
Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.
The development of science: A focus on computer simulations
Ignacio Pagonabarraga, Director of CECAM, lifts the lid on the field of computer simulations and the crucial role they have played in the development of science since the second half of the last century.
The role of plants in drugs and medicines
Dr Deborah Lee from Dr Fox Online Pharmacy sheds light on the role of plants in drugs and medicines in this absorbing analysis.
Existing drugs should be used to treat COVID-19 instead of vaccine
Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
Researchers test drug that stops early stages of COVID-19
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
The ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde
Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, details the ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde, as well as his thoughts on the value of a chemistry degree.
Supporting mental health services, alcohol and drug use in Ireland
Here, we find out how Minister for Health, Simon Harris TD is helping to support mental health services, as well as alcohol and drug use issues in Ireland.
The Psychedelic Renaissance and the importance of drug policy reform
In the view of Amanda Feilding, Founder of the Beckley Foundation, “Psychedelics are unique pharmacological compounds that hold the promise of a profound paradigm shift in psychiatry.” Here, we learn about the Psychedelic Renaissance and the importance of drug policy reform.
‘Green’ asthma inhalers would reduce drug costs
Researchers at Cambridge have found that 'green' asthma inhalers would both reduce carbon emissions and reduce drug costs.
Academia: An important player in the drug discovery ecosystem
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
Medical marijuana: Developments in the industry
Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.
Point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.